Xinfuda to Exhibit at CPHI & PMEC China 2026

Xinfuda is pleased to announce its participation in CPHI & PMEC China 2026, one of Asia's leading pharmaceutical industry exhibitions. The event will take place from June 16–18, 2026 at the Shanghai New International Expo Center (SNIEC), China.

Xinfuda will welcome global pharmaceutical and biotech partners at Booth N5E12, where the company will showcase its latest pharmaceutical packaging and drug delivery solutions.

Exhibition Information

Event: CPHI & PMEC China 2026

Date: June 16–18, 2026

Venue: Shanghai New International Expo Centre

Booth: N5E12

Showcasing Advanced Pharmaceutical Packaging & Injection Pen Solutions

During the exhibition, Xinfuda will present a range of innovative products and technologies, including:

Disposable injection pens

Reusable injection pen systems

GLP-1 drug delivery devices

Desiccant bottles and moisture-proof packaging

COP vials and pharmaceutical containers

Child-resistant pharmaceutical packaging solutions

The company’s products are manufactured under ISO 15378 and ISO 13485 certified quality systems, supporting the needs of global pharmaceutical and biotech companies.

Supporting the Growing Biologics and GLP-1 Market

As demand for biologics, peptide therapies, and GLP-1 treatments continues to grow worldwide, Xinfuda remains committed to providing reliable and compliant pharmaceutical packaging and drug delivery solutions.

The company continues to expand its capabilities in:

Pharmaceutical primary packaging

Drug delivery device development

OEM/ODM customization

Injection pen manufacturing

Meet Xinfuda at Booth N5E12

Xinfuda warmly invites industry professionals, pharmaceutical manufacturers, and global partners to visit Booth N5E12 during CPHI & PMEC China 2026.

Xinfuda Medical Packaging is a manufacturer specializing in pharmaceutical packaging and injection pen systems. The company provides solutions for biologics, GLP-1 therapies, peptide drugs, and other pharmaceutical applications, serving customers in global regulated markets.